THEODORE ROSEN to Male
This is a "connection" page, showing publications THEODORE ROSEN has written about Male.
Connection Strength
0.256
-
A case of filgrastim-induced neutrophilic dermatosis of the dorsal hands in a patient with Felty Syndrome. Dermatol Online J. 2023 Dec 15; 29(6).
Score: 0.034
-
"The Raven Himself Is Hoarse:" Candida dubliniensis fungemia manifesting as an eschar. Skinmed. 2022; 20(3):213-214.
Score: 0.031
-
Intramuscular lipoma of the scapular region. Dermatol Online J. 2021 Jul 15; 27(7).
Score: 0.029
-
Sexually Transmitted Diseases in the COVID-19 Era. Skinmed. 2020; 18(4):210-212.
Score: 0.027
-
Efficacy and Safety of Ozenoxacin Cream for Treatment of Adult and Pediatric Patients With Impetigo: A Randomized Clinical Trial. JAMA Dermatol. 2018 07 01; 154(7):806-813.
Score: 0.023
-
Cutaneous leishmaniasis mimicking squamous cell carcinoma. Dermatol Online J. 2017 Jan 15; 23(1).
Score: 0.021
-
Prevalence and awareness of actinic keratosis: barriers and opportunities. J Am Acad Dermatol. 2013 Jan; 68(1 Suppl 1):S2-9.
Score: 0.016
-
The rate of melanoma transection with various biopsy techniques and the influence of tumor transection on patient survival. J Am Acad Dermatol. 2013 Mar; 68(3):452-8.
Score: 0.016
-
Azithromycin as an alternative rosacea therapy when tetracyclines prove problematic. J Drugs Dermatol. 2008 Sep; 7(9):898-9.
Score: 0.012
-
Etanercept therapy for silicone granuloma. J Drugs Dermatol. 2006 Oct; 5(9):894-6.
Score: 0.010
-
Cutaneous amebiasis in a child and review of the literature. Pediatr Dermatol. 2006 May-Jun; 23(3):231-4.
Score: 0.010
-
Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients With Impetigo: Pooled Analysis of Phase 3 Clinical Trials. J Drugs Dermatol. 2018 Oct 01; 17(10):1051-1057.
Score: 0.006
-
A Phase 2 Controlled Study of SB206, a Topical Nitric Oxide-Releasing Drug for Extragenital Wart Treatment. J Drugs Dermatol. 2018 Oct 01; 17(10):1100-1105.
Score: 0.006
-
Recurrence of moderately dysplastic nevi with positive histologic margins. J Am Acad Dermatol. 2017 Mar; 76(3):527-530.
Score: 0.005
-
Porokeratosis of Mibelli: Successful treatment with 5 percent topical imiquimod and topical 5 percent 5-fluorouracil. Dermatol Online J. 2010 Dec 15; 16(12):10.
Score: 0.003
-
Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cycles. J Am Acad Dermatol. 2010 Apr; 62(4):573-81.
Score: 0.003
-
A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions. J Drugs Dermatol. 2007 Oct; 6(10):1001-8.
Score: 0.003